Page last updated: 2024-09-02

fingolimod hydrochloride and Hantavirus Pulmonary Syndrome

fingolimod hydrochloride has been researched along with Hantavirus Pulmonary Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dalrymple, NA; Gavrilovskaya, IN; Gorbunova, EE; Mackow, ER	1

Other Studies

1 other study(ies) available for fingolimod hydrochloride and Hantavirus Pulmonary Syndrome

Article	Year
Role of vascular and lymphatic endothelial cells in hantavirus pulmonary syndrome suggests targeted therapeutic approaches. Lymphatic research and biology, 2013, Volume: 11, Issue:3 Topics: Animals; Antibodies; Capillary Permeability; Cricetinae; Endothelial Cells; Fingolimod Hydrochloride; Hantavirus Pulmonary Syndrome; Host-Pathogen Interactions; Humans; Immunosuppressive Agents; Mesocricetus; Orthohantavirus; Propylene Glycols; Pulmonary Edema; Signal Transduction; Sirolimus; Sphingosine; Vascular Endothelial Growth Factor Receptor-2	2013

Article

Year

Role of vascular and lymphatic endothelial cells in hantavirus pulmonary syndrome suggests targeted therapeutic approaches.

Lymphatic research and biology, 2013, Volume: 11, Issue:3

Topics: Animals; Antibodies; Capillary Permeability; Cricetinae; Endothelial Cells; Fingolimod Hydrochloride; Hantavirus Pulmonary Syndrome; Host-Pathogen Interactions; Humans; Immunosuppressive Agents; Mesocricetus; Orthohantavirus; Propylene Glycols; Pulmonary Edema; Signal Transduction; Sirolimus; Sphingosine; Vascular Endothelial Growth Factor Receptor-2

2013